8-KRegulation FDExhibits & Filings

CME GROUP INC. 8-K Report, Regulation FD Disclosure (Nov 29, 2023)

Filed November 29, 2023For Securities:CME

Summary

CME Group Inc. (CME) filed an 8-K on November 28, 2023, primarily to disclose upcoming pricing changes that will become effective on February 1, 2024. These adjustments were communicated to clients via a Special Executive Report, which has been made available on the company's website. While the filing itself doesn't provide specific details on the nature or extent of these price changes, the effective date indicates a forward-looking adjustment to CME Group's service fees. Investors should note that this 8-K filing is largely procedural, focusing on the communication of pricing updates rather than significant financial results or operational developments. The company is leveraging Regulation FD to ensure broad dissemination of this information to its client base. Further details regarding the impact of these pricing changes on CME Group's revenue and profitability would likely be found in subsequent financial reports or investor communications.

Key Highlights

  • 1CME Group announced pricing changes affecting its clients.
  • 2The new pricing will be effective starting February 1, 2024.
  • 3The information regarding pricing changes was disseminated via a Special Executive Report.
  • 4The Special Executive Report has been posted to CME Group's company website.
  • 5This filing serves as a Regulation FD disclosure, ensuring broad communication of the pricing update.
  • 6The 8-K does not contain detailed financial statements or specific financial performance metrics.

Frequently Asked Questions

The primary purpose of this 8-K filing is to disclose upcoming pricing changes that CME Group Inc. is implementing for its clients, which will take effect on February 1, 2024. It serves as a formal notification to the market under Regulation FD.

This filing does not provide specific details about the nature or magnitude of the pricing changes. It only states that changes have been communicated to clients via a Special Executive Report and provides the effective date of February 1, 2024.

More information about the pricing changes can be found in the Special Executive Report (SER 9295) that CME Group communicated to its clients. This report has been posted to the company's official website.

No, this 8-K filing does not report on CME Group's financial performance. It is solely a disclosure of upcoming pricing adjustments and does not include financial statements or operational results.